A recent study conducted by researchers at Boston University School of Public Health reveals a concerning gap in mental health treatment among U.S. college students diagnosed with psychosis. Despite a majority acknowledging the need for mental health support, nearly 60 percent of these students do not receive the recommended combined therapy and antipsychotic medication, highlighting significant barriers in accessing comprehensive care. This gap may have profound implications for early intervention strategies and long-term outcomes for young adults grappling with psychotic disorders.
Psychosis, a serious psychiatric condition that typically first presents in late adolescence or early adulthood, affects around three percent of the U.S. population. One of the greatest challenges in managing psychosis lies in the delay between symptom onset and treatment, which averages over 70 weeks nationwide. Such delays often exacerbate symptom severity and lead to worse functional outcomes. Given that college students fall squarely within this critical age window, understanding their treatment patterns is vital for public health approaches aimed at mitigating long-term disability and societal costs associated with psychosis.
The study, published in the journal Social Psychiatry and Psychiatric Epidemiology, employed extensive analysis of the Healthy Minds Study data, which surveys mental health among college students across the United States. Investigators specifically focused on responses from 2,819 students who reported a psychosis diagnosis between 2015 and 2024. The research sought to quantify treatment utilization, examine perceived need for services, and assess the role of informal support in facilitating or hindering access to recommended care modalities, including antipsychotic medication and therapy.
Findings reveal a paradoxical landscape: approximately 80 percent of surveyed students acknowledged they needed support for their mental health concerns, and a similar proportion sought therapy or counseling within the preceding year. However, only around 40 percent reported the use of antipsychotic medication, despite clinical guidelines emphasizing the efficacy of combined pharmacological and psychotherapeutic approaches in managing psychotic disorders. This discrepancy points towards systemic obstacles such as stigma, lack of medication access, or possible apprehensions about medication side effects that may deter students from full-fledged treatment engagement.
These results underscore the importance of early identification and intervention in psychosis among college populations. Early and sustained treatment with both antipsychotic medications and counseling has been shown to reduce symptom severity, enhance quality of life, improve school and occupational functioning, and lower relapse risk. Thus, the underuse of antipsychotic drugs in this group could contribute to poorer disease trajectories and increased burden on health systems and educational institutions alike.
A particularly illuminating aspect of the study was the exploration of support networks’ influence on treatment-seeking behaviors. Students who believed they needed help and perceived encouragement from friends, family, health professionals, or campus personnel were more likely to adhere to treatment recommendations, including medication. Conversely, individuals who felt pressured or coerced into seeking help, such as through institutionalization mandates, showed diminished engagement. This finding suggests that fostering voluntary, supportive environments may enhance adherence and patients’ subjective health experiences.
Moreover, the researchers highlight how internalized stigma and skepticism about treatment efficacy remain formidable barriers. Mental health stigma within college campuses can silence early disclosure of symptoms and dissuade students from accessing comprehensive care. National awareness campaigns like Mental Health Awareness Month spearheaded by organizations such as the National Alliance on Mental Illness (NAMI) aim to combat these challenges, but the persistence of treatment gaps calls for more targeted strategies tailored to populations with psychotic disorders.
The research team advocates for future longitudinal studies to examine long-term outcomes associated with voluntary treatment-seeking encouraged by informal supports versus mandated interventions. Better understanding these nuances could inform policies and programs designed to build patient-centered care frameworks that prioritize autonomy and constructive social support while ensuring timely initiation of evidence-based treatment.
Additionally, clarifying the multifaceted barriers obstructing antipsychotic medication uptake is imperative. These may include formulary restrictions, affordability issues, limited access to psychiatric providers, and concerns about medication side effects, which have been well-documented as factors deterring adherence. Addressing these challenges through policy reform, enhanced education, and integrated care models within university health services could narrow treatment disparities and improve prognoses.
As psychosis onset typically occurs around age 20, the college years represent a critical juncture for intervention. Incorporating routine screening for psychotic symptoms, expanding mental health resources, promoting psychoeducation, and reducing stigma on campuses can establish protective mechanisms to encourage earlier treatment uptake. This study’s findings invite multidisciplinary collaboration among clinicians, educators, policymakers, and student advocates to design holistic programs that better meet the needs of this vulnerable population.
In conclusion, this investigation into mental health help-seeking among college students with psychosis unveils a pressing public health issue — despite recognition of need and willingness to engage in therapy, medication use remains insufficient. This treatment gap threatens to compromise recovery potential and underscores the urgency of dismantling barriers to comprehensive care. Early engagement, supportive social networks, and destigmatizing initiatives will be key components in improving overall outcomes for young adults with psychosis, ultimately fostering healthier campus communities and reducing the societal burden of untreated mental illness.
Subject of Research: People
Article Title: Mental health help-seeking by US college students with a diagnosis of psychosis
News Publication Date: May 20, 2026
Web References:
- Social Psychiatry and Psychiatric Epidemiology Journal Article
- Healthy Minds Study
- Mental Health Awareness Month – NAMI
References:
- Godoy-Henderson et al., Social Psychiatry and Psychiatric Epidemiology, 2026.
- US epidemiological data on psychosis prevalence and treatment delays.
Keywords: Psychosis, psychotic disorders, mental health, college students, health care policy, public health, psychiatric medication, therapy, mental health stigma, early intervention
